Advertisement World Vaccine Congress Europe, 28-31 October - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

World Vaccine Congress Europe, 28-31 October

Research, Development and Strategic Partnerships for the Global Vaccine Industry

Logo
WHITE PAPERS
PRODUCTS & SERVICES
Quick Contact World Vaccine Congress Europe, 28-31 October
LATEST PRESS RELEASES


LATEST VIDEOS

World Vaccine Congress Europe, 28-31 October

The World Vaccine Congress Europe is an exhibition and series of conferences designed to promote research, development and strategic partnerships for the global vaccine industry.  

The World Vaccine Congress Europe is an exhibition and series of conferences designed to promote research, development and strategic partnerships for the global vaccine industry.

Taking place 28-31 October in Barcelona, the event is one of the biggest and most established European vaccine event with more than 250 speakers.

The event is expected to draw more than 700 professionals in the vaccine industry, creating opportunities for hundreds of networking hours.

World Vaccine Congress Europe will explore the complete vaccine value chain. Key visitors will include government officials, academia, and big pharma, biotech and small-to-medium-sized-enterprise (SME) biotech companies.

Progressive, scientific and strategic solutions for the vaccine industry

World Vaccine Congress Europe provides a platform where the pharmaceutical service provider community and their partners can discuss scientific, clinical and strategic advances and opportunities.

The event has already confirmed more than 200 speakers, including representatives from the Human Vaccine Project, the Organisation for Economic Cooperation and Development (OECD) and the Coalition for Epidemic Preparedness Innovations (CEPI).

Speakers include:

  • Dr Marion Gruber: director of the Office of Vaccines Research and Review for the US Food and Drug Administration (FDA)
  • Dr Wolfgang Philipp: acting head of unit for crisis management and preparedness in health at DG SANTE for the European Commission (EC)
  • Dr Ann Moen: chief influenza preparedness and response for the World Health Organisation (WHO)
  • Dr Maria Elena Bottazzi: associate dean of the National School of Tropical Medicine, professor of paediatrics and molecular virology and microbiology at the Baylor College of Medicine, co-head at the Section of Pediatric Tropical Medicine, and co-director of the Texas Children’s Hospital Center for Vaccine Development
  • Dr Laszlo Radvanyi: president and scientific director at the Ontario Institute for Cancer Research
  • Dr Josie Golding: lead of epidemic preparedness at the Wellcome Trust
  • Dr Martin Friede: group lead for the transfer of technology for health products at WHO
  • Dr Melanie Saville: director of vaccine development at The Coalition for Epidemic Preparedness Innovations (CEPI)
  • Dr Sarah Gilbert: professor of vaccinology at the University of Oxford
  • Dr Annaliesa Anderson: vice-president of CSO Bacterial Vaccines at Pfizer
  • Annelies Wilder-Smith: Professor at The London School of Hygiene & Tropical Medicine (LSHTM)
  • Herman Goosens: professor of microbiology at the UA, director of the Department of Clinical Pathology at the University Hospital in Antwerp, and member of clinical research organisation ECRAID and the COMBACTE EU-IMI programme
  • Magda Chlebus: executive director of science policy and regulatory affairs at The European Federation of Pharmaceutical Industries (EFPIA)
  • Dr Gabrielle Breugelmans: director of research at the Access to Medicine Foundation
  • Sheuli Porkess: executive director of research, medical and innovation at the Association of the British Pharmaceutical Industry (ABPI)
  • Professor Kees Melief: chief science officer (CSO) at ISA Pharmaceuticals
  • Dr Merribeth Morin: cycle lead at CARB-X
  • Mark Pearson: deputy director of labour and social affairs at the Organisation for Economic Co-operation and Development  (OECD)
  • Wayne Koff: CEO of the Human Vaccines Project
  • Dr Carlota Dobaño Lázaro: associate research professor and head of the Malaria Immunology Group at ISGlobal
  • Noemi Garcia del Blanco: head of veterinary biologicals and emerging therapies at the European Medicines Agency (EMA)

Networking opportunities throughout Europe

The 20th edition of the World Vaccine Congress Europe will be co-located with the fifth World Veterinary Vaccine Congress and the fourth Immuno-Oncology Profiling Congress. These events will allow visitors to meet key decision makers in a wide range of areas.

There will be opportunities to find contacts that are seeking solutions to challenges around the commercial and scientific issues in manufacturing, clinical trials, strategy, regulation, veterinary vaccines, immune profiling, anti-microbial resistance (AMR), respiratory diseases, influenza and emerging vaccines.

World Vaccine Congress Europe will provide delegates with progressive, scientific and strategic solutions, supporting the production of more cost-effective vaccines through executive-level commentary, case studies and real-time analysis from key stakeholders

Of the total exhibitors, 10% are expected to be from the biotech industry, 25% involved in supply chain activities, 20% from the pharmaceutical sector, 10% from government organisations, 10% from academia / research institutions, and 5% from non-profit organisations or charities.

Big pharma and biotech companies that attended in 2018 include AB Agri, Bioaster, Cellectis, Genentech, Inovio, Mazen Animal Health and Novartis.

Interactive workshops to explore the pharmaceutical and biotech industry topics

World Vaccine Congress Europe will feature a wide range of workshops, including:

  • Funding and Investment for Animal Health: Speaker Roxanne Feller will discuss the investment opportunities are available for the animal health biologics field
  • Vaccine Market Access and Regulatory Affairs: Speakers Gabrielle Brugelmans and Yelda Momeni will explain how to receive optimal value for vaccines and avoid the pitfalls when launching a new vaccine
  • Active and Passive Immunity: How Do We Induce Maternal Immunisation in Humans and Animals?: Speaker Gregory Glenn discusses what we understand about the role of maternal immunity in human and animal health, and what the human health industry can learn from the veterinary sector
  • Liquid Biopsy for Non-Invasive Tumour Biopsy and Improvement of Patient-Treatment Outcomes: Speaker Karen-Lise Spindler talks about how to overcome the limitations of liquid biopsies.

Thought leadership presentations, panel discussions and exhibition stands

Throughout World Vaccine Congress Europe, companies will be delivering their key messages at thought leader presentations on a chosen topic.

Panel discussions, roundtables, branding promotions, case study presentations, technology showcases and exhibition stands also provide companies’ access to more than 500 vaccine industry decision makers.

The event will also feature extended lunch periods in the exhibition hall, which will provide companies time to network between sessions. These lunch formats allow for more opportunities for casual conversations and introductions.

Contact

World Vaccine Congress Europe
Palau de Congressos de Catalunya
Av. Diagonal, 661-671
Barcelona, Spain
08028
Download the congress agenda
See World Vaccine Congress website

Quick Contact World Vaccine Congress Europe, 28-31 October


Top Products from World Vaccine Congress Europe, 28-31 October

Quick Contact World Vaccine Congress Europe, 28-31 October
Quick Contact World Vaccine Congress Europe, 28-31 October
Quick Contact World Vaccine Congress Europe, 28-31 October


Quick Contact World Vaccine Congress Europe, 28-31 October
Quick Contact World Vaccine Congress Europe, 28-31 October
Quick Contact World Vaccine Congress Europe, 28-31 October


Contact World Vaccine Congress Europe, 28-31 October

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.

Confirmation

Finally, complete a quick security check and confirm terms and conditions:

Quick Contact World Vaccine Congress Europe, 28-31 October